Introduction: Severity and disease progression in people with Cystic Fibrosis (CF) is typically dependent on their genotype. One potential therapeutic strategy for people with specific mutations is exon skipping with antisense oligonucleotides (AO). CFTR exon 9 is an in-frame exon and hence the exclusion of this exon would excise only 31 amino acids but not alter the reading frame of the remaining mRNA. Splice mutations 1209 + 1 G > C and 1209 + 2 T > G were documented to cause CFTR exon 9 skipping and these variants were reported to manifest as a milder CF disease, therefore exon 9 skipping could be beneficial for people with class I mutations that affect exon 9 such as p.Trp401X. While the impact of exon 9 skipping on gene expression and ...
Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in ...
The CFTR splicing mutation 3849 + 10 kb C --> T creates a novel donor site 10 kilobases (kb) into in...
AbstractAnimal models of cystic fibrosis, in particular several different mutant mouse strains obtai...
Introduction: Over 2000 different mutations have been reported in patients with CF and found to occu...
Introduction/Aim. Over 2000 different mutations have been reported in patients with Cystic Fibrosis ...
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully unders...
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully unders...
Recently we have created a mouse model of cystic fibrosis (CF) by insertional gene targeting to exon...
A gene-targeting construct was made containing 7.8 kilobases of DNA spanning exon 10 of the mouse cy...
The rate of exon 9 exclusion from the cystic fibrosis transmembrane conductance regulator (CFTR) mRN...
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibros...
In monosymptomatic forms of cystic fibrosis such as congenital bilateral absence of vas deferens, va...
Introduction: Over 2000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ...
International audienceWith the increased number of identified nucleotide sequence variations in gene...
Animal models of cystic fibrosis (CF) are essential for investigating disease mechanisms and trialin...
Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in ...
The CFTR splicing mutation 3849 + 10 kb C --> T creates a novel donor site 10 kilobases (kb) into in...
AbstractAnimal models of cystic fibrosis, in particular several different mutant mouse strains obtai...
Introduction: Over 2000 different mutations have been reported in patients with CF and found to occu...
Introduction/Aim. Over 2000 different mutations have been reported in patients with Cystic Fibrosis ...
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully unders...
The molecular basis of the skipping of constitutive exons in many messenger RNAs is not fully unders...
Recently we have created a mouse model of cystic fibrosis (CF) by insertional gene targeting to exon...
A gene-targeting construct was made containing 7.8 kilobases of DNA spanning exon 10 of the mouse cy...
The rate of exon 9 exclusion from the cystic fibrosis transmembrane conductance regulator (CFTR) mRN...
Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibros...
In monosymptomatic forms of cystic fibrosis such as congenital bilateral absence of vas deferens, va...
Introduction: Over 2000 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) ...
International audienceWith the increased number of identified nucleotide sequence variations in gene...
Animal models of cystic fibrosis (CF) are essential for investigating disease mechanisms and trialin...
Nonsense mutations are present in 10% of patients with CF, produce a premature termination codon in ...
The CFTR splicing mutation 3849 + 10 kb C --> T creates a novel donor site 10 kilobases (kb) into in...
AbstractAnimal models of cystic fibrosis, in particular several different mutant mouse strains obtai...